FIELD: medicine, pharmaceutics.
SUBSTANCE: controlled release solid preparation contains a combination of (1) an antacid, (2) an immediate release portion containing a proton pump inhibitor, preferentially lansoprazole, and a basic substance, and (3) a delayed release portion comprising a proton pump inhibitor and a pH-independent material.
EFFECT: solid preparation according to the invention shows an increase in gastric pH up to 4 or higher 0,5 h after oral administration into a mammal and a retention time at pH 4 or higher for at least 14 hours a day.
16 cl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CONTROLLED RELEASE SOLID DRUG | 2006 |
|
RU2467740C2 |
| METHOD OF OBTAINING OF PREPARATION WITH COVERING | 2004 |
|
RU2359671C2 |
| METHOD OF ANTIDEMENTIA DRUG STABILISATION | 2005 |
|
RU2401125C2 |
| PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | 2010 |
|
RU2580652C2 |
| PHARMACEUTICAL COMPOSITION FOR CONTROLLED RELEASE OF ACTIVE SUBSTANCES AND METHOD FOR ITS PREPARING | 2003 |
|
RU2291711C2 |
| LAMOTRIGINE-BASED COMPOSITIONS OF PROLONGED RELEASE | 2003 |
|
RU2325163C2 |
| TABLET, WHICH IS DECOMPOSED IN MOUTH | 2008 |
|
RU2478375C2 |
| COMPOSITION CONTAINING FINE DISPERSED LONG RELEASING PARTICLES FOR QUICK-DISPOSABLE IN BUCCAL CAVERN TABLETS | 2002 |
|
RU2245136C2 |
| SLOW-RELEASE MATRIX PREPARATION CONTAINING BASE AGENT OR ITS SALT AND METHOD FOR MAKING THEREOF | 2005 |
|
RU2390354C2 |
| TABLET WITH ENTEROSOLUBLE COATING AND METHOD OF PREPARING | 1998 |
|
RU2201217C2 |
